Use access key #2 to skip to page content.
$3.45 -0.67 (-16.26%)
10/15/2008 4:00 PM

Repligen Corp (RGEN)

CAPS Rating:
****

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

View All Commentary (RGEN)

Recs

0

Avatar TMFStockpick08 (< 20) Submitted: 5/27/08 9:43 AM : Outperform Start Price: $5.81 RGEN Score: -6.02

This stock was picked by TMFOrangeblood for the 2008 Stockpicking Contest.

Report this Post Replies: 0 | Reply

Featured Broker Partners

Sponsored Links